Philippines Centralises Regulation of Animal Health Products Under Bureau of Animal Industry

Regulatory reform aims to streamline approvals for veterinary medicines, biologics and feed additives while strengthening oversight of the country’s livestock sector

The Philippine Department of Agriculture (DA) has formally transferred regulatory authority over animal health products to the Bureau of Animal Industry (BAI), marking one of the country’s most significant veterinary regulatory reforms in recent years. The move is designed to simplify the approval process for veterinary medicines, vaccines, biologics, feed additives and other animal health products by placing regulatory oversight under a single specialised agency.

The transfer implements provisions of the Animal Industry Development and Competitiveness Act (Republic Act No. 12308), which shifted responsibility for regulating veterinary products from the Food and Drug Administration (FDA) to the Department of Agriculture’s Bureau of Animal Industry. While the legislative framework took effect in late 2025, the Department of Agriculture has now issued the procedural guidelines needed for the Bureau of Animal Industry to fully exercise its licensing and regulatory functions.

Centralised Oversight for Animal Health Products

Under the new regulatory framework, the Bureau of Animal Industry assumes primary responsibility for the registration, licensing and post-market regulation of veterinary drugs, vaccines, biologics, diagnostic products, feed additives and other animal health products intended for livestock and companion animals.

The reform is intended to create a more efficient regulatory pathway by consolidating scientific assessment, product registration, licensing and industry oversight within the agency responsible for animal health and livestock disease control. Officials expect the change to reduce administrative duplication while improving coordination between product regulation and national animal disease management programmes.

Industry Expects Faster Product Approvals

The Philippine animal health industry has welcomed the centralisation of regulatory authority, with many stakeholders expecting shorter approval timelines and greater regulatory clarity.

Previously, companies developing or importing veterinary pharmaceuticals and biological products often navigated overlapping regulatory processes involving multiple government agencies. By concentrating regulatory responsibility within the Bureau of Animal Industry, the Department of Agriculture aims to establish a more specialised and predictable approval system that better reflects the technical requirements of veterinary medicines.

The Bureau has also been expanding digital regulatory services, including online application platforms for licensing and registration, as part of broader efforts to modernise regulatory operations.

Strengthening Livestock Health and Biosecurity

The regulatory reform comes at a time when the Philippines continues to strengthen disease prevention and livestock recovery programmes following outbreaks of African swine fever (ASF), avian influenza and other transboundary animal diseases.

By aligning product regulation more closely with national veterinary services, policymakers expect faster access to innovative vaccines, diagnostics and veterinary medicines that support disease surveillance, outbreak response and livestock productivity.

Industry observers note that a specialised regulatory authority may also improve coordination during emergency disease situations by enabling closer integration between product approvals and national animal health programmes.

Opportunities for Global Animal Health Companies

The streamlined regulatory framework is expected to benefit both domestic manufacturers and multinational animal health companies seeking to introduce new veterinary products into the Philippine market.

Manufacturers of vaccines, pharmaceuticals, parasiticides, feed additives and veterinary biologics may experience a more transparent regulatory environment, potentially accelerating commercial launches and expanding producer access to new technologies.

The Philippines represents one of Southeast Asia’s important livestock markets, with growing commercial poultry, swine and aquaculture sectors driving demand for advanced animal health solutions. Simplified regulatory procedures could enhance the country’s attractiveness as a regional market for veterinary innovation.

Transition Arrangements Remain in Place

The Department of Agriculture has clarified that products previously approved by the Food and Drug Administration will continue to remain valid until the expiration of their existing authorisations. Applications submitted under the previous system are being transitioned to the Bureau of Animal Industry in accordance with the government’s implementation guidelines, ensuring continuity for manufacturers and importers during the regulatory transition.

Broader Regulatory Modernisation

The centralisation of veterinary product regulation forms part of a wider effort by the Philippine government to strengthen the competitiveness of the country’s animal agriculture sector through improved governance, modernised regulatory systems and enhanced biosecurity.

Alongside the transfer of veterinary product oversight, recent reforms have focused on improving disease surveillance, expanding laboratory capacity, strengthening livestock traceability and supporting the commercialisation of new animal health technologies, including African swine fever vaccines.

For international companies supplying veterinary pharmaceuticals, biologics and feed technologies, the revised regulatory framework is expected to provide a clearer pathway for market entry while supporting the government’s broader objective of improving livestock productivity, animal welfare and food security.

Outlook

The transfer of regulatory authority to the Bureau of Animal Industry represents a structural shift in the Philippines’ veterinary regulatory landscape. By consolidating oversight under a specialised technical agency, the government aims to create a more efficient approval system for animal health products while strengthening national disease control programmes.

As implementation progresses, the effectiveness of the new framework will be measured by its ability to accelerate product registrations, maintain rigorous safety and efficacy standards, and improve access to innovative veterinary medicines and biologics for the country’s livestock and companion animal sectors.